HERBALIFE LTD. annual report, FY2022

Herbalife Nutrition Ltd. — FY2022 Form 10-K Summary

Reporting period: Fiscal year ended December 31, 2022; filed February 14, 2023. This is an annual report, not a standalone fourth-quarter report; the provided filing text does not give clear standalone Q4 financial results.

Business context

Herbalife sells nutrition and wellness products through independent Members in 95 markets. Its direct-selling model depends on Member recruitment, retention, and sales productivity. Approximately 77% of FY2022 net sales came from outside the United States. The Formula 1 shake line accounted for about 26% of net sales.

Key financial metrics

MetricFY2022FY2021Change
Net sales$5,204.4 million$5,802.8 millionDown 10.3% reported; down 5.4% in local currency
Gross profit / margin$4,030.8 million / 77.4%$4,563.5 million / 78.6%Margin down 119 basis points
Operating income / margin$545.2 million / 10.5%$734.1 million / 12.7%Down 25.7%
Net income / diluted EPS$321.3 million / $3.23$447.2 million / $4.13Net income down 28.2%
Operating cash flow$352.5 million$460.3 millionDown $107.8 million
Capital expenditures$156.2 million cash purchases of PP&E; $164.1 million including accrued capex$156.4 million cash purchases of PP&E—

Cost of sales was 22.6% of revenue, versus 21.4% in 2021. Royalty overrides were 32.4% of sales, versus 31.6%; SG&A was $1,810.4 million, or 34.8% of sales, compared with $2,012.1 million, or 34.6%. The income statement included a $12.8 million gain from repurchasing a portion of the 2024 convertible notes. The effective tax rate was 24.4%, versus 20.3%.

Liquidity and debt

Cash and cash equivalents were $508.0 million, down from $601.5 million. Working capital was $379.5 million, up from $351.4 million. Total debt carrying value was $2,692.0 million, including $29.5 million current; long-term debt was $2,662.5 million. The company reported a shareholders’ deficit of $1,265.9 million. It was in compliance with credit-facility covenants at year-end. Management said cash, operating cash flow, available revolver capacity, and capital-market access were expected to support foreseeable needs; no mandatory 2023 prepayment of the Term Loan B was required under the stated calculation.

Material changes and regional trends

  • Worldwide Volume Points fell 10.1%. The company attributed the decline to lower volume, Member recruitment and retention challenges, pandemic-related comparisons, inflation, currency effects, and market-specific conditions.
  • Sales fell in North America 11.7%, Latin America 4.5%, EMEA 19.2%, and China 37.9%; Asia Pacific increased 6.4%. India sales rose 30.4%.
  • Price increases across most markets partly offset lower volumes. The company cited unfavorable foreign exchange effects and higher raw material, labor, freight, and manufacturing costs as pressures on results.
  • Operating cash flow declined, primarily reflecting lower earnings, partly offset by favorable working-capital movements. Lower China sales also reduced service-fee expense.

Outlook, risks, and unusual items

  • Outlook: No formal revenue or earnings guidance is provided in the supplied text. Management expects 2023 capital expenditures of approximately $175 million to $225 million. A separate, multi-year Digital Technology Program is expected to total about $400 million and keep capital expenditures elevated through 2025.
  • Transformation Program: Expected to deliver at least $70 million in annual savings, with approximately half expected in 2023 and the remainder largely in 2024. Management expects at least $60 million of total pretax costs; about $25 million had been incurred through year-end 2022. Completion is expected in 2024.
  • Margins: Management expects gross margin to remain under pressure in 2023, particularly from raw materials, manufacturing labor, and freight costs. It is assessing further pricing actions amid inflation.
  • Key risks: Member retention and recruitment; regulation of products and network marketing; compliance with the FTC Consent Order; competition; reliance on the Formula 1 product line; foreign exchange and inflation; China-specific regulatory and operating risks; supply-chain and cybersecurity disruption; and high debt and refinancing requirements.
  • Legal and tax matters: A proposed $12.5 million settlement in the Rodgers class action was reserved but still subject to court approval. The filing describes tax and customs disputes in Mexico, Brazil, India, and Korea, among other matters; outcomes and potential losses are uncertain. The company reported $72.5 million of unrecognized tax benefits, including interest and penalties.
  • Other items: In December 2022, the company issued $277.5 million of 2028 convertible notes and used proceeds to repurchase $287.5 million principal amount of 2024 notes. It repurchased $131.8 million of shares in 2022; no shares were repurchased in Q4. It has not paid cash dividends since 2014. The auditor gave unqualified opinions on the financial statements and internal control over financial reporting.

Important facts for investors to verify

  • Review the full financial statements and debt note for maturity, refinancing, interest-rate, covenant, and convertible-note exposure, especially the disclosed debt maturities in 2024 and 2025.
  • Assess whether Member recruitment, retention, and sales volumes stabilize, and whether price increases can offset cost inflation without further reducing demand.
  • Track China’s sales and contribution margin, alongside the impact of its modified business model and regulatory requirements.
  • Compare actual 2023–2025 Digital Technology Program spending and Transformation Program savings with management’s estimates.
  • Follow developments in the pending class-action settlement, tax assessments, and compliance obligations under the FTC Consent Order and FCPA-related agreements.